Omaxe Limited (OMAXE) AI Stock Analysis

Omaxe Limited

(NSE:OMAXE)

Select Model

Rating:41.6Neutral

Price Target:INR 87.00▼(-7.50% Downside)

Action:reiterated

Date:10/31/26

The overall score is severely depressed by the company's precarious financial state, marked by deep losses and negative equity. This fundamental weakness is compounded by bearish technical momentum and a negative P/E ratio, leaving the stock with a high-risk profile and no clear positive catalysts.

Positive Factors

Diversified development platformOmaxe’s presence across residential, commercial, township and urban infrastructure projects gives it multiple avenues for development activity and revenue generation. Geographic and segment breadth can support business resilience over the next several quarters by reducing reliance on a single property category or location.

Negative Factors

Persistent unprofitable operationsSustained negative gross and operating profit indicates that Omaxe’s projects have not produced durable operating margins, while the larger 2026 net loss shows continued earnings deterioration. Persistent unprofitability can constrain reinvestment, weaken stakeholder confidence, and reduce the capacity to absorb execution setbacks.

Omaxe Limited (OMAXE) vs. iShares MSCI India ETF (INDA)

Market Cap: INR 16.56B
Dividend Yield: ―
Average Volume (3M): 157.12K
Price to Earnings (P/E): -4.5
Beta (1Y): 1.61
Revenue Growth: 16.72%
EPS Growth: 43.38%
Country: India
Employees: 468
Sector: General
Sector Strength: 55
Industry: Real Estate - Development

Omaxe Limited Business Overview & Revenue Model

Company Description

Omaxe Limited is an Indian entity actively involved in the property development sector. Its primary activities encompass the construction and sale of a varied range of projects, including integrated and high-tech townships, collective housing initiat...

Omaxe Limited Financial Statement Overview

Summary

Financial health is critically weak. Persistent net losses (net margin -52% in FY2026), negative shareholders' equity, and a sharp reversal to negative operating cash flow indicate severe solvency and liquidity stress, despite a large asset base.

Income Statement

10Very Negative

Balance Sheet

5Very Negative

Cash Flow

8Very Negative

Financial statement breakdown
Breakdown	TTM	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Income Statement
Total Revenue	14.81B	13.40B	15.61B	16.14B	7.73B	6.18B
Gross Profit	-3.01B	-4.91B	-4.50B	-1.75B	-929.60M	601.70M
EBITDA	-4.16B	-6.09B	-5.32B	-3.48B	-2.87B	-415.40M
Net Income	-5.10B	-6.97B	-6.86B	-4.03B	-3.48B	-1.60B
Balance Sheet
Total Assets	0	165.22B	148.77B	138.22B	135.60B	119.18B
Cash, Cash Equivalents and Short-Term Investments	9.09B	9.09B	7.44B	5.40B	4.93B	1.28B
Total Debt	0	14.66B	7.96B	6.79B	11.07B	11.28B
Total Liabilities	8.93B	174.15B	150.74B	133.33B	126.50B	106.58B
Stockholders Equity	-8.93B	-9.02B	-2.05B	4.80B	8.98B	12.45B
Cash Flow
Free Cash Flow	-664.20M	-4.85B	3.28B	9.70B	4.49B	7.66B
Operating Cash Flow	-568.70M	-4.55B	3.52B	9.87B	4.69B	7.83B
Investing Cash Flow	1.02B	165.70M	-1.55B	-640.20M	-1.42B	-221.50M
Financing Cash Flow	2.84B	6.28B	-863.50M	-9.24B	-2.62B	-7.40B

Omaxe Limited Technical Analysis

Technical Analysis SentimentNegative

Last Price94.05

Price Trends

50DMA112.04Negative

100DMA98.87Negative

200DMA87.93Positive

Market Momentum

MACD-3.90Positive

RSI34.05Neutral

STOCH8.06Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:OMAXE, the sentiment is Negative. The current price of 94.05 is below the 20-day moving average (MA) of 103.68, below the 50-day MA of 112.04, and above the 200-day MA of 87.93, indicating a neutral trend. The MACD of -3.90 indicates Positive momentum. The RSI at 34.05 is Neutral, neither overbought nor oversold. The STOCH value of 8.06 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:OMAXE.

Omaxe Limited Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

IN:OMAXE against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
IN:AJMERA	62Neutral	INR 26.03B	16.87	―	0.76%	43.12%	12.31%
IN:SHRIRAMPPS	62Neutral	INR 10.90B	11.95	―	―	33.44%	13.37%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
IN:ARVSMART	55Neutral	INR 25.92B	13.85	―	0.40%	5.31%	54.09%
IN:KOLTEPATIL	50Neutral	INR 39.37B	31.59	―	―	7.76%	27.78%
IN:OMAXE	42Neutral	INR 16.60B	-4.49	―	―	16.72%	43.38%
IN:ARIHANTSUP	39Underperform	INR 8.87B	30.77	―	0.12%	4.66%	-51.13%

* General Sector Average

Performance Comparison

IN:OMAXE and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
IN:OMAXE	Omaxe Limited	90.75	10.95	13.72%
IN:AJMERA	Ajmera Realty & Infra India Ltd	132.25	-76.22	-36.56%
IN:ARIHANTSUP	Arihant Superstructures Limited	205.20	-217.26	-51.43%
IN:ARVSMART	Arvind SmartSpaces Ltd.	564.55	-47.79	-7.80%
IN:KOLTEPATIL	Kolte-Patil Developers Limited	443.90	11.35	2.62%
IN:SHRIRAMPPS	Shriram Properties Ltd.	63.89	-31.27	-32.86%

Omaxe Limited Corporate Events

Omaxe Board to Review September Quarter Results; Trading Window Stays Shut

Oct 22, 2026

Omaxe Limited has notified the stock exchanges that its Board of Directors will meet on October 27, 2026 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. In li...

Omaxe Shareholders Clear All Resolutions at Digitally Conducted 37th AGM

Sep 25, 2026

Omaxe Limited has reported the voting results of its 37th Annual General Meeting, held on September 25, 2026 via video conferencing and other audio-visual means, in line with regulatory and pandemic-era governance guidelines. All resolutions proposed...

Omaxe Subsidiary Secures RERA Nod for Lucknow Commercial Project

Aug 11, 2026

Omaxe Garv Buildtech Private Limited, a wholly owned subsidiary of Omaxe Limited, has secured Real Estate Regulatory Authority registration for its Commercial-3 Block-4 project in Lucknow, clearing the way for a formal launch on August 12, 2026. The...

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 31, 2026

Omaxe Limited AI Stock Analysis